Coronavirus detection method and kit

By using RNA extraction, reverse transcription and Cas13a-guided fluorescent probe shearing technology in coronavirus detection, the problem of false negative and specificity detection in the prior art is solved, and the rapid and sensitiveness of the coronavirus is achieved. High and strong specificity detection, suitable for clinical diagnosis and screening.

CN119061205APending Publication Date: 2024-12-03CHONGQING MEDICAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411469025.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-21
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing coronavirus detection methods such as qPCR have false negative defects and low specificity of the test results, and gene sequencing is not suitable for rapid screening. Antibody testing requires waiting for an immune response, which cannot meet the needs of rapid diagnosis.

Method used

By performing RNA extraction, reverse transcription, amplification and retranscription of the samples, specific shearing is used to use Cas13a-guided RNA fluorescence probe and nuclease to achieve fluorescence detection of RNA, providing simple operation, high sensitivity and specificity Strong detection methods and kits.

Benefits of technology

It has realized the specific detection of SARS-CoV-1 and SARS-CoV-2 coronaviruses, and has the advantages of not requiring PCR amplification conditions, good stability, economical and practicality, and meets the needs of rapid clinical diagnosis and screening.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119061205A_ABST
    Figure CN119061205A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of coronavirus detection, in particular to a coronavirus detection method and kit.The coronavirus detection method comprises the following steps that samples are collected, the collected samples are stored in a unified mode, RNA of the to-be-detected samples is extracted, reverse transcriptase is added for in-vitro reverse transcription to synthesize cDNA, and the cDNA is extracted; dNA polymerase and RNA polymerase are added for amplification and re-transcription, nuclease, nuclease guide RNA, an RNA fluorescent probe and a buffer solution are added for reaction, a fluorescent reaction product is obtained, and the reaction product is detected by using a fluorescent plate reader. According to the method, coronavirus RNA is subjected to reverse transcription, amplification and re-transcription in vitro so as to realize targeted molecular amplification from RNA to RNA, and then the RNA fluorescent probe is subjected to shearing through Cas13a sequence-mediated specific nuclease Cas13a activation, so that fluorescence is detected. The kit has the advantages of simplicity in operation, high sensitivity, strong specificity, no need of PCR (Polymerase Chain Reaction) amplification conditions, good stability, economy, practicability and the like, and can meet the requirements of clinical rapid diagnosis and screening.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of coronavirus detection, and in particular to a coronavirus detection method and a kit. Background Art

[0002] Coronaviruses (CoVs) belong to the Coronaviridae family, a large family of viruses that are widely present in nature and can infect humans and animals. They are named after the corona-like spikes on the surface of their virus particles observed under an electron microscope. The genome of coronaviruses is relatively large, with a single-stranded positive-strand gene sequence of 26 to 32 kb, making it the longest RNA virus known in nature. The ongoing epidemic of novel coronavirus infection (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first broke out in late December 2019 and now poses an unprecedented threat to global public health and the economy.

[0003] At present, the pathogen diagnosis of viral diseases caused by the new coronavirus is mainly carried out by gene amplification methods (such as constant temperature amplification method, qPCR method), gene sequencing method, antibody detection method (immunoluminescence method, etc.), etc. Among them, qPCR method is the most commonly used and has high sensitivity. However, the use of qPCR method for the detection of new coronaviruses such as 2019-nCoV requires a strict PCR amplification laboratory, and the qPCR method has certain false negative defects. In addition, although the gene sequencing method has more reliable test results, it cannot be used for rapid screening or testing. The antibody detection method can only be detected after the patient has produced sufficient immune response, and has the defect of low specificity of the test results.

[0004] Therefore, it is necessary to provide a coronavirus detection method and kit to solve the above technical problems. Summary of the invention

[0005] In order to solve the above technical problems, the present invention provides a method and a kit for detecting coronavirus.

[0006] The coronavirus detection method provided by the present invention comprises the following steps:

[0007] S1. Collect samples and store them uniformly;

[0008] S2, extracting RNA from the sample to be tested, adding reverse transcriptase to perform in vitro reverse transcription to synthesize cDNA;

[0009] S3, adding DNA polymerase and RNA polymerase for amplification and re-transcription;

[0010] S4, adding nuclease, nuclease-guided RNA, RNA fluorescent probe and buffer to react and obtain a fluorescent reaction product;

[0011] S5. Use a fluorescent plate reader to detect the reaction products to obtain the detection results of RNA with a specific gene sequence and make a judgment on the results.

[0012] Preferably, the sample collected in S1, i.e. the sample to be tested, comes from a human nasopharyngeal swab, saliva, sputum sample, alveolar lavage fluid sample, blood sample, lower respiratory tract secretion, stool sample or environmental sample.

[0013] Preferably, the RNA polymerase in S3 is T7 RNA polymerase, the nuclease in S4 is Cas13a, the 5' end of the RNA fluorescent probe is connected to a fluorescent reporter group, and the 3' end is connected to a fluorescent quencher group.

[0014] Preferably, the fluorescent reporter group is selected from any one of FAM, HEX, ROX or CY5, and the fluorescent quencher group is selected from any one of BHQ1 or BHQ2.

[0015] Preferably, the fluorescence plate reader in S5 uses a 96-well plate or a 384-well plate.

[0016] Coronavirus test kits, including testing tools and reagents.

[0017] The detection tool includes an instruction manual, a cotton swab, a bracket, a reagent bottle, and a test paper;

[0018] The reagents include nuclease Cas13a, Cas13a guide RNA for specific detection of gene sequences, RNA fluorescent probe, reverse transcriptase, DNA polymerase, T7 RNA polymerase and buffer.

[0019] Preferably, the reverse transcriptase comprises a reverse primer consisting of a sequence that can be recognized and transcribed by T7 RNA polymerase and a complementary sequence targeting viral RNA.

[0020] Compared with the related art, the coronavirus detection method and kit provided by the present invention have the following advantages:

[0021] Beneficial effects:

[0022] The present invention uses the above-mentioned detection method, and the coronavirus RNA is reverse transcribed, amplified and re-transcribed in vitro to achieve RNA-to-RNA targeted molecular amplification, and then the RNA fluorescent probe is sheared by the activation of the specific nuclease Cas13a mediated by the Cas13a sequence, thereby detecting fluorescence. The present invention can be used for specific detection of SARS-CoV-1 and SARS-CoV-2 coronaviruses, with the advantages of simple operation, high sensitivity, strong specificity, no need for PCR amplification conditions, good stability, economical and practical, and can meet the needs of clinical rapid diagnosis and screening. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 A schematic diagram of a preferred embodiment of the coronavirus detection method and kit provided by the present invention;

[0024] Figure 2 The principle steps of the coronavirus detection method;

[0025] Figure 3 Schematic diagram of the magnetic bead extraction process for RNA extraction in S2. DETAILED DESCRIPTION

[0026] In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Generally, the components of the embodiments of the present invention described and shown in the drawings here can be arranged and designed in various different configurations.

[0027] Therefore, the following detailed description of the embodiments of the present invention provided in the accompanying drawings is not intended to limit the scope of the invention claimed for protection, but merely represents selected embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0028] The following is a detailed description of the detection method and the specific implementation of the coronavirus kit in conjunction with specific embodiments.

[0029] This embodiment discloses a kit for detecting coronavirus RNA. The kit is used for efficient and rapid specific detection of coronavirus RNA to quickly and effectively distinguish positive samples from negative samples.

[0030] Specifically, the kit includes detection tools and reagents.

[0031] The detection tool includes an instruction manual, a cotton swab, a bracket, a reagent bottle, and a test paper;

[0032] The reagents include nuclease Cas13a, Cas13a guide RNA for specific detection of gene sequences, RNA fluorescent probe, reverse transcriptase, DNA polymerase, T7 RNA polymerase and buffer

[0033] Among them, the nuclease Cas13a is selected from bacteria, yeast, insects, mammalian cell lines or other biological protein expression systems.

[0034] The Cas13a guide RNA contains the nuclease Cas13a recognition sequence and the targeting viral RNA complementary sequence.

[0035] Nuclease Cas13a is a nuclease targeting RNA. The activation of nuclease Cas13a requires guide RNA.

[0036] Cas13a guide RNA contains Cas13a-specific recognition signals and target RNA complementary sequences. After the target RNA complementary sequence is complementary to the corresponding RNA molecule, the enzymatic activity of the nuclease Cas13a is activated and the target molecule is sheared. More importantly, once the nuclease Cas13a is activated, the nuclease Cas13a can non-specifically hydrolyze other nearby RNA molecules, thereby forming a signal amplification effect.

[0037] The 5' end of the RNA fluorescent probe is labeled with a fluorescent reporter group, and the 3' end of the RNA fluorescent probe is labeled with a fluorescent quencher group; wherein the fluorescent reporter group is selected from any one of FAM, HEX, TET, JOE, NED, VIC, CY3, CY5, ROX or TAMRA, and the fluorescent quencher group is selected from any one of MGB, BQH1, BQH2 or Phosphorothioate.

[0038] The probe molecule is cleaved by the nuclease Cas13a, which activates the RNase activity and releases fluorescence, which is detected by the fluorescence plate reader.

[0039] Reverse transcriptase contains a reverse primer consisting of a sequence that can be recognized and transcribed by T7 RNA polymerase and a complementary sequence to the targeted viral RNA. Reverse transcriptase uses RNA as a template and forms double-stranded DNA after reverse transcription. The enzyme catalyzes the synthesis of a DNA chain complementary to a specific gene sequence. The synthesis of a complementary DNA chain is completed in the presence of a primer.

[0040] The kit disclosed in this embodiment can reverse transcribe, amplify and re-transcribe coronavirus RNA in vitro to achieve targeted molecular amplification of RNA to RNA, and then activate the specific nuclease Cas13a mediated by the Cas13a sequence to shear the RNA fluorescent probe, thereby detecting fluorescence. The present invention can be used for specific detection of coronavirus, with simple operation, high sensitivity, strong specificity, and no need for PCR amplification conditions and other technical advantages. The kit can be used for rapid detection in laboratory, clinical and other use environments.

[0041] according to Figure 1 , Figure 2 As shown, the coronavirus detection method provided by the present invention comprises the following steps:

[0042] S1. Collect samples and store them uniformly;

[0043] S2, extracting RNA from the sample to be tested, adding reverse transcriptase to perform in vitro reverse transcription to synthesize cDNA;

[0044] S3, adding DNA polymerase and RNA polymerase for amplification and re-transcription;

[0045] S4, adding nuclease, nuclease-guided RNA, RNA fluorescent probe and buffer to react and obtain a fluorescent reaction product;

[0046] S5. Use a fluorescent plate reader to detect the reaction products to obtain the detection results of RNA with a specific gene sequence and make a judgment on the results.

[0047] In an embodiment of the present invention, the sample collected in S1 is the sample to be tested, and its source includes human nasopharyngeal swab, saliva, sputum sample, alveolar lavage fluid sample, blood sample, lower respiratory tract secretion, stool sample or environmental sample.

[0048] In an embodiment of the present invention, the RNA polymerase in S3 is T7 RNA polymerase, the nuclease in S4 is Cas13a, the 5' end of the RNA fluorescent probe is connected to a fluorescent reporter group, and the 3' end is connected to a fluorescent quencher group.

[0049] Preferably, the fluorescence plate reader in S5 uses a 96-well plate or a 384-well plate.

[0050] In an embodiment of the present invention, the fluorescent reporter group is selected from any one of FAM, HEX, ROX or CY5, and the fluorescent quencher group is selected from any one of BHQ1 or BHQ2;

[0051] It should be noted that: the RNA of the sample to be tested in S2 can be extracted by any known extraction method, such as: Qiagen kit extraction method, Trizol LS organic solvent extraction method, magnetic bead extraction method;

[0052] according to Figure 3 As shown, in the present invention, the magnetic bead extraction method is specifically used for operation, and the specific steps are:

[0053] 1. Sample preparation: Obtain samples from tissues or cells of interest and ensure that the samples are sufficient for subsequent experiments;

[0054] 2. Preparation of RNA extraction reagents: Prepare all necessary reagents according to Q IAGEN's magnetic bead RNA extraction kit;

[0055] 3. Sample lysis: Mix the sample with the lysis buffer and lyse under appropriate conditions. This usually involves using a grinder or homogenizer to break the sample into small pieces;

[0056] 4. Magnetic bead binding: Add magnetic beads to the lysate and mix well. The magnetic beads will bind to the RNA for subsequent purification.

[0057] 5. Remove impurities: Remove impurities bound to RNA by washing the magnetic beads. Depending on the instructions of the kit, several washing steps may be required;

[0058] 6. Elution of RNA: Elute the RNA from the magnetic beads. This step usually involves using a specific elution

[0059] 7. Quantitative and qualitative analysis of RNA: Use spectrophotometer or electrophoresis to perform quantitative and qualitative analysis on the extracted RNA;

[0060] 8. Storage and use of RNA: Store the extracted RNA under appropriate conditions for subsequent experiments;

[0061] Through the above detection method, coronavirus RNA is reverse transcribed, amplified and re-transcribed in vitro to achieve targeted molecular amplification of RNA to RNA, and then the RNA fluorescent probe is cleaved by the activation of the specific nuclease Cas13a mediated by the Cas13a sequence, thereby detecting fluorescence.

[0062] The present invention can specifically detect coronaviruses, and has the advantages of simple operation, high sensitivity, strong specificity, no need for PCR amplification conditions, good stability, economy and practicality, etc., and can meet the needs of clinical rapid diagnosis and screening;

[0063] In an embodiment of the present invention, the fluorescence plate reader in S5 uses a 96-well plate or a 384-well plate.

[0064] The results can be read in a fixed or dynamic manner using a fluorescence plate reader.

[0065] The fluorescence plate reader uses 96-well plates or 384-well plates. At the same time, in order to detect reliability, positive control group and negative control group can be set in the fluorescence plate reader;

[0066] The positive control group is a reaction tube containing in vitro synthesized RNA fragments containing the target virus (i.e., coronaviruses of SARS-CoV-1 and SARS-CoV-2) sequence, and the negative control group is not added with Cas13a guide RNA relative to the mixture in the reaction tube for detecting the target gene sequence.

[0067] The working principle of the coronavirus detection method and kit provided by the present invention is as follows:

[0068] The coronavirus RNA is reverse transcribed, amplified and re-transcribed in vitro to achieve targeted molecular amplification of RNA to RNA, and then the RNA fluorescent probe is cleaved by activation of the specific nuclease Cas13a mediated by the Cas13a sequence, thereby detecting fluorescence.

[0069] The series of detailed descriptions listed above are only specific descriptions of feasible implementation methods of the present invention. They are not intended to limit the scope of protection of the present invention. Any equivalent implementation methods or changes that do not deviate from the technical spirit of the present invention should be included in the scope of protection of the present invention.

[0070] It will be apparent to those skilled in the art that the present invention is not limited to the details of the exemplary embodiments described above and that the present invention can be implemented in other specific forms without departing from the spirit or essential features of the present invention. Therefore, the embodiments should be considered exemplary and non-restrictive in all respects, and the scope of the present invention is defined by the appended claims rather than the above description, and it is intended that all changes falling within the meaning and scope of the equivalent elements of the claims be included in the present invention.

[0071] In addition, it should be understood that although this specification is described in terms of implementation methods, not every implementation method contains only one independent technical solution. This narrative method of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation methods that can be understood by those skilled in the art.

Claims

1. Coronavirus detection methods, It is characterized in that The following steps are involved: S1. Collect samples and store them uniformly; S2, extracting RNA from the sample to be tested, adding reverse transcriptase to perform in vitro reverse transcription to synthesize cDNA; S3, adding DNA polymerase and RNA polymerase for amplification and re-transcription; S4, adding nuclease, nuclease-guided RNA, RNA fluorescent probe and buffer to react and obtain a fluorescent reaction product; S5. Use a fluorescent plate reader to detect the reaction products to obtain the detection results of RNA with a specific gene sequence and make a judgment on the results.

2. The method for detecting coronavirus according to claim 1, It is characterized in that The samples collected in S1 are samples to be tested, and their sources include: Human nasopharyngeal swabs, saliva, sputum samples, bronchoalveolar lavage fluid samples, blood samples, lower respiratory tract secretions, stool samples or environmental samples.

3. The method for detecting coronavirus according to claim 1, It is characterized in that The RNA polymerase in S3 is T7 RNA polymerase, the nuclease in S4 is Cas13a, the 5' end of the RNA fluorescent probe is connected to a fluorescent reporter group, and the 3' end is connected to a fluorescent quencher group.

4. The method for detecting coronavirus according to claim 3, It is characterized in that The fluorescent reporter group is selected from any one of FAM, HEX, ROX or CY5, and the fluorescent quencher group is selected from any one of BHQ1 or BHQ2.

5. The method for detecting coronavirus according to claim 1, It is characterized in that The fluorescence plate reader in the S5 uses a 96-well plate or a 384-well plate.

6. Test kit for coronavirus, It is characterized in that Including nuclease Cas13a, Cas13a guide RNA for specific detection of gene sequences, RNA fluorescent probe, reverse transcriptase, DNA polymerase, T7 RNA polymerase and buffer.

7. The coronavirus kit according to claim 6, It is characterized in that Also included are detection tools, which include instructions for use, cotton swabs, brackets, reagent bottles and test strips.

8. The coronavirus kit according to claim 6, It is characterized in that The reverse transcriptase comprises a reverse primer consisting of a sequence that can be recognized and transcribed by T7 RNA polymerase and a complementary sequence of the targeted viral RNA.